A phase 2 study of pembrolizumab and weekly paclitaxel for platinum-resistant epithelial ovarian cancer.
Saved in:
| Title: | A phase 2 study of pembrolizumab and weekly paclitaxel for platinum-resistant epithelial ovarian cancer. |
|---|---|
| Authors: | Wenham RM; Moffitt Cancer Center, Department of Gynecologic Oncology, Tampa, FL, USA. Electronic address: robert.wenham@moffitt.org., Buras AL; Salem Health, Gynecologic Oncology, Salem, OR, USA., Gordon SW; Sidney Kimmel Comprehensive Cancer Center, Division of Hematology and Oncology, Thomas Jefferson University, Philadelphia, PA, USA; Massey Comprehensive Cancer Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Virginia Commonwealth University, Richmond, VA, USA., Whiting J; Moffitt Cancer Center, Department of Biostatistics & Bioinformatics, Tampa, FL, USA., Fridley BL; Children's Mercy Kansas City, Division of Health Services and Outcomes Research, Kansas City, MO, USA., Dorman D; Clinical Trials Office, Moffitt Cancer Center, Tampa, FL, USA., Apte SM; Moffitt Cancer Center, Department of Gynecologic Oncology, Tampa, FL, USA., Chon HS; Moffitt Cancer Center, Department of Gynecologic Oncology, Tampa, FL, USA., Shahzad MM; Moffitt Cancer Center, Department of Gynecologic Oncology, Tampa, FL, USA., Randall LM; Massey Comprehensive Cancer Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Virginia Commonwealth University, Richmond, VA, USA; Inova Health System, Gynecologic Oncology Women's Service Line, Fairfax, VA, USA., Havrilesky LJ; Duke University Medical Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke Cancer Institute., Davidson BA; Duke University Medical Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke Cancer Institute., Secord AA; Duke University Medical Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke Cancer Institute. |
| Source: | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2026 Jun; Vol. 36 (6), pp. 102856. Date of Electronic Publication: 2025 Dec 13. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: BMJ Country of Publication: United States NLM ID: 9111626 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41558878 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A phase 2 study of pembrolizumab and weekly paclitaxel for platinum-resistant epithelial ovarian cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wenham+RM%22">Wenham RM</searchLink>; Moffitt Cancer Center, Department of Gynecologic Oncology, Tampa, FL, USA. Electronic address: robert.wenham@moffitt.org.<br /><searchLink fieldCode="AU" term="%22Buras+AL%22">Buras AL</searchLink>; Salem Health, Gynecologic Oncology, Salem, OR, USA.<br /><searchLink fieldCode="AU" term="%22Gordon+SW%22">Gordon SW</searchLink>; Sidney Kimmel Comprehensive Cancer Center, Division of Hematology and Oncology, Thomas Jefferson University, Philadelphia, PA, USA; Massey Comprehensive Cancer Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Virginia Commonwealth University, Richmond, VA, USA.<br /><searchLink fieldCode="AU" term="%22Whiting+J%22">Whiting J</searchLink>; Moffitt Cancer Center, Department of Biostatistics & Bioinformatics, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Fridley+BL%22">Fridley BL</searchLink>; Children's Mercy Kansas City, Division of Health Services and Outcomes Research, Kansas City, MO, USA.<br /><searchLink fieldCode="AU" term="%22Dorman+D%22">Dorman D</searchLink>; Clinical Trials Office, Moffitt Cancer Center, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Apte+SM%22">Apte SM</searchLink>; Moffitt Cancer Center, Department of Gynecologic Oncology, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Chon+HS%22">Chon HS</searchLink>; Moffitt Cancer Center, Department of Gynecologic Oncology, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Shahzad+MM%22">Shahzad MM</searchLink>; Moffitt Cancer Center, Department of Gynecologic Oncology, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Randall+LM%22">Randall LM</searchLink>; Massey Comprehensive Cancer Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Virginia Commonwealth University, Richmond, VA, USA; Inova Health System, Gynecologic Oncology Women's Service Line, Fairfax, VA, USA.<br /><searchLink fieldCode="AU" term="%22Havrilesky+LJ%22">Havrilesky LJ</searchLink>; Duke University Medical Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke Cancer Institute.<br /><searchLink fieldCode="AU" term="%22Davidson+BA%22">Davidson BA</searchLink>; Duke University Medical Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke Cancer Institute.<br /><searchLink fieldCode="AU" term="%22Secord+AA%22">Secord AA</searchLink>; Duke University Medical Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke Cancer Institute. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229111626%22">International journal of gynecological cancer : official journal of the International Gynecological Cancer Society</searchLink> [Int J Gynecol Cancer] 2026 Jun; Vol. 36 (6), pp. 102856. <i>Date of Electronic Publication: </i>2025 Dec 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase II; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ%22">BMJ </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9111626 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1525-1438 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221048891X%22">1048891X </searchLink><i>NLM ISO Abbreviation: </i>Int J Gynecol Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41558878 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ijgc.2025.102856 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 102856 Titles: – TitleFull: A phase 2 study of pembrolizumab and weekly paclitaxel for platinum-resistant epithelial ovarian cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wenham RM – PersonEntity: Name: NameFull: Buras AL – PersonEntity: Name: NameFull: Gordon SW – PersonEntity: Name: NameFull: Whiting J – PersonEntity: Name: NameFull: Fridley BL – PersonEntity: Name: NameFull: Dorman D – PersonEntity: Name: NameFull: Apte SM – PersonEntity: Name: NameFull: Chon HS – PersonEntity: Name: NameFull: Shahzad MM – PersonEntity: Name: NameFull: Randall LM – PersonEntity: Name: NameFull: Havrilesky LJ – PersonEntity: Name: NameFull: Davidson BA – PersonEntity: Name: NameFull: Secord AA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2026 Jun Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1525-1438 Numbering: – Type: volume Value: 36 – Type: issue Value: 6 Titles: – TitleFull: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society Type: main |
| ResultId | 1 |